metricas
covid
Revista Colombiana de Reumatología (English Edition) Factors associated with the use of tumor necrosis factor alpha inhibitors in a p...
Journal Information

Statistics

Follow this link to access the full text of the article

Original Investigation
Factors associated with the use of tumor necrosis factor alpha inhibitors in a population of Colombian patients with spondyloarthritis
Factores asociados con el uso de inhibidores del factor de necrosis tumoral alfa en una población de pacientes colombianos con espondiloartritis
Luis Fernando Pinto-Peñarandaa,b, Andrés Felipe Echeverri-Garcíaa, Mauricio Restrepo-Escobarb,c, María Fernanda Álvarez Barreneched, Alejandro Hurtadoe, Javier D. Márquez-Hernándeza,
Corresponding author
Jadamarq@yahoo.com

Corresponding author.
a Internal Medicine and Rheumatology, Pablo Tobón Uribe Hospital, Medellín, Colombia
b Internist and Rheumatologist with a Master's Degree in Epidemiology, Pablo Tobón Uribe Hospital, Medellín, Colombia. University of Antioquia, Medellín, Colombia
c Internal Medicine and Rheumatology, University of Antioquia, Medellín, Colombia
d Department of Internal Medicine, Faculty of Medicine, Clínica Cardiovid, Medellín, Colombia
e Faculty of Medicine, CES University, Medellín, Colombia
Read
1465
Times
was read the article
235
Total PDF
1230
Total HTML
Share statistics
Article information
ISSN: 24444405
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 18 6 24
2025 11 47 27 74
2025 10 34 11 45
2025 9 42 15 57
2025 8 60 10 70
2025 7 93 11 104
2025 6 45 3 48
2025 5 41 3 44
2025 4 33 5 38
2025 3 33 8 41
2025 2 41 2 43
2025 1 50 3 53
2024 12 24 0 24
2024 11 27 1 28
2024 10 18 6 24
2024 9 46 3 49
2024 8 38 4 42
2024 7 19 4 23
2024 6 12 3 15
2024 5 19 0 19
2024 4 27 7 34
2024 3 35 3 38
2024 2 20 1 21
2024 1 23 2 25
2023 12 28 1 29
2023 11 32 7 39
2023 10 26 1 27
2023 9 18 0 18
2023 8 16 1 17
2023 7 18 2 20
2023 6 12 1 13
2023 5 14 1 15
2023 4 11 0 11
2023 3 14 0 14
2023 2 15 2 17
2023 1 16 5 21
2022 12 19 4 23
2022 11 17 4 21
2022 10 15 8 23
2022 9 17 7 24
2022 8 16 8 24
2022 7 13 9 22
2022 6 17 5 22
2022 5 25 6 31
2022 4 15 6 21
2022 3 0 2 2
2021 8 7 3 10
2021 7 4 14 18
Show all

Follow this link to access the full text of the article